Real-time enrollment status for this aml clinical trial
Current Status
Recruiting
Checked: September 1, 2026 at 3:16 AM UTC
| NCT Number | NCT06976736 |
| Recruiting Status | Recruiting |
| Condition | AML |
| Phase | Clinical Trial |
| Target Enrollment | 1,000 participants |
| Active Locations | 2 sites in the US |
| Sponsor | TScan Therapeutics, Inc. |
| Last Updated on CT.gov | September 10, 2025 (Sep 10, 2025) |
As of September 1, 2026: Clinical trial NCT06976736 is currently recruiting participants. This clinical trial study for aml is actively seeking new participants at 2 locations across the United States. The study is sponsored by TScan Therapeutics, Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06976736 is actively recruiting participants as of September 1, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 2 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06976736 was last updated Sep 10, 2025 (September 10, 2025). HelloStudys verifies this status automatically.